Generate Biomedicines Inc's (NASDAQ:GENB) Lock-Up Period To End on August 26th
MarketBeat
Generate Biomedicines' (NASDAQ:GENB - Get Free Report) lock-up period will end on Wednesday, August 26th. Generate Biomedicines had issued 25,000,000 shares in its public offering on February 27th. The total size of the offering was $400,000,000 based on an initial share price of $16.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.
NASDAQ:GENB
